Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), multiple system atrophy (MSA), Huntington's disease (HD), and amyotrophic lateral sclerosis (ALS), are characterized by progressive neuronal degeneration leading to severe cognitive and motor impairments. Traditional diagnostic methods are limited by cost, sensitivity, accessibility, and patient discomfort, highlighting the urgent need for innovative, diagnostic, and therapeutic strategies. Recent research has increasingly focused on the role of extracellular vesicles (EVs) in neurodegenerative diseases. EVs, secreted by all cell types, are crucial for cellular communication. They transfer proteins, lipids, and nucleic acids, thereby influencing various physiological and pathological processes. This chapter explores the biogenesis and functions of brain-derived EVs, their involvement in the central nervous system (CNS) microenvironment during neurodegeneration, and their contribution to disease progression and pathology. The unique molecular signatures of EVs from different brain cell types are examined to understand their specific roles and interactions in neurodegenerative contexts. Additionally, the chapter highlights the therapeutic potential of EVs, discussing current research and clinical trials investigating their use as biomarkers for early diagnosis and as vehicles for delivering therapeutic agents. Techniques for isolating, characterizing, and analyzing brain-originating EVs and their biomarkers are thoroughly discussed, providing insights into technological advancements and methodological challenges in the field. Finally, the chapter addresses challenges and future directions, emphasizing the need for standardization in EV research, regulatory considerations, and the potential for EVs in personalized medicine. This comprehensive overview underscores the current state and future prospects of EV-based diagnostics and therapeutics in neurodegenerative diseases.

Original publication

DOI

10.1016/B978-0-443-28822-7.00008-8

Type

Chapter

Book title

The Neurodegeneration Revolution: Emerging Therapies and Sustainable Solutions

Publication Date

01/01/2024

Pages

309 - 340